Cargando…
IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling
T cell repertoire diversity and clonotype follow-up in vaccination, cancer, infectious and immune diseases represent a major challenge owing to the enormous complexity of the data generated. Here we describe a next generation methodology, which combines 5′RACE PCR, 454 sequencing and, for analysis,...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778833/ https://www.ncbi.nlm.nih.gov/pubmed/23995877 http://dx.doi.org/10.1038/ncomms3333 |
_version_ | 1782285168945397760 |
---|---|
author | Li, Shuo Lefranc, Marie-Paule Miles, John J. Alamyar, Eltaf Giudicelli, Véronique Duroux, Patrice Freeman, J. Douglas Corbin, Vincent D. A. Scheerlinck, Jean-Pierre Frohman, Michael A. Cameron, Paul U. Plebanski, Magdalena Loveland, Bruce Burrows, Scott R. Papenfuss, Anthony T. Gowans, Eric J. |
author_facet | Li, Shuo Lefranc, Marie-Paule Miles, John J. Alamyar, Eltaf Giudicelli, Véronique Duroux, Patrice Freeman, J. Douglas Corbin, Vincent D. A. Scheerlinck, Jean-Pierre Frohman, Michael A. Cameron, Paul U. Plebanski, Magdalena Loveland, Bruce Burrows, Scott R. Papenfuss, Anthony T. Gowans, Eric J. |
author_sort | Li, Shuo |
collection | PubMed |
description | T cell repertoire diversity and clonotype follow-up in vaccination, cancer, infectious and immune diseases represent a major challenge owing to the enormous complexity of the data generated. Here we describe a next generation methodology, which combines 5′RACE PCR, 454 sequencing and, for analysis, IMGT, the international ImMunoGeneTics information system (IMGT), IMGT/HighV-QUEST web portal and IMGT-ONTOLOGY concepts. The approach is validated in a human case study of T cell receptor beta (TRB) repertoire, by chronologically tracking the effects of influenza vaccination on conventional and regulatory T cell subpopulations. The IMGT/HighV-QUEST paradigm defines standards for genotype/haplotype analysis and characterization of IMGT clonotypes for clonal diversity and expression and achieves a degree of resolution for next generation sequencing verifiable by the user at the sequence level, while providing a normalized reference immunoprofile for human TRB. |
format | Online Article Text |
id | pubmed-3778833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Pub. Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-37788332013-09-23 IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling Li, Shuo Lefranc, Marie-Paule Miles, John J. Alamyar, Eltaf Giudicelli, Véronique Duroux, Patrice Freeman, J. Douglas Corbin, Vincent D. A. Scheerlinck, Jean-Pierre Frohman, Michael A. Cameron, Paul U. Plebanski, Magdalena Loveland, Bruce Burrows, Scott R. Papenfuss, Anthony T. Gowans, Eric J. Nat Commun Article T cell repertoire diversity and clonotype follow-up in vaccination, cancer, infectious and immune diseases represent a major challenge owing to the enormous complexity of the data generated. Here we describe a next generation methodology, which combines 5′RACE PCR, 454 sequencing and, for analysis, IMGT, the international ImMunoGeneTics information system (IMGT), IMGT/HighV-QUEST web portal and IMGT-ONTOLOGY concepts. The approach is validated in a human case study of T cell receptor beta (TRB) repertoire, by chronologically tracking the effects of influenza vaccination on conventional and regulatory T cell subpopulations. The IMGT/HighV-QUEST paradigm defines standards for genotype/haplotype analysis and characterization of IMGT clonotypes for clonal diversity and expression and achieves a degree of resolution for next generation sequencing verifiable by the user at the sequence level, while providing a normalized reference immunoprofile for human TRB. Nature Pub. Group 2013-09-02 /pmc/articles/PMC3778833/ /pubmed/23995877 http://dx.doi.org/10.1038/ncomms3333 Text en Copyright © 2013, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Article Li, Shuo Lefranc, Marie-Paule Miles, John J. Alamyar, Eltaf Giudicelli, Véronique Duroux, Patrice Freeman, J. Douglas Corbin, Vincent D. A. Scheerlinck, Jean-Pierre Frohman, Michael A. Cameron, Paul U. Plebanski, Magdalena Loveland, Bruce Burrows, Scott R. Papenfuss, Anthony T. Gowans, Eric J. IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling |
title | IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling |
title_full | IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling |
title_fullStr | IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling |
title_full_unstemmed | IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling |
title_short | IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling |
title_sort | imgt/highv quest paradigm for t cell receptor imgt clonotype diversity and next generation repertoire immunoprofiling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778833/ https://www.ncbi.nlm.nih.gov/pubmed/23995877 http://dx.doi.org/10.1038/ncomms3333 |
work_keys_str_mv | AT lishuo imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT lefrancmariepaule imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT milesjohnj imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT alamyareltaf imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT giudicelliveronique imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT durouxpatrice imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT freemanjdouglas imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT corbinvincentda imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT scheerlinckjeanpierre imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT frohmanmichaela imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT cameronpaulu imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT plebanskimagdalena imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT lovelandbruce imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT burrowsscottr imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT papenfussanthonyt imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling AT gowansericj imgthighvquestparadigmfortcellreceptorimgtclonotypediversityandnextgenerationrepertoireimmunoprofiling |